Fountain Healthcare Partners
Fountain Healthcare Partners is an Irish-based life science venture capital fund. Fountain is exclusively focused on the life science
Business Model:
Revenue: $11.4M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Fountain Healthcare Partners Information
Geographic Data
Address: Guild Street, IFSC
City: Dublin
State: county dublin
Zip:
Country: IE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$378M
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2020 | Inotrem | Series B | 5.5M |
| 9/2019 | Neuromod Devices | Series A | 8.7M |
| 6/2014 | Chrono Therapeutics | Series A | 32M |
| 5/2013 | Trino Therapeutics | Series A | 11.6M |
| 9/2016 | Vivasure Medical | Series C | 18.3M |
| 7/2021 | NeRRe Therapeutics | Series B | 0 |
| 8/2009 | Palyon Medical | Series A | 24M |
| 1/2021 | Neurent Medical | Series B | 0 |
| 7/2012 | Neuravi | Series A | 6.4M |
| 4/2018 | MMI | Series A | 24.8M |
| 5/2018 | Neurent Medical | Venture Round | 10.8M |
| 9/2012 | Mainstay Medical | Series B | 20M |
| 6/2015 | Neuravi | Series B | 21.5M |
| 9/2013 | Civitas Therapeutics | Series B | 0 |
| 7/2022 | MMI | Series B | 0 |
| 10/2009 | Amarin | Post-IPO Equity | 70M |
| 10/2018 | Velicept Therapeutics | Series B | 15M |
| 2/2018 | Syndesi Therapeutics | Series A | 21.3M |
| 6/2009 | Opsona | Series B | 4.6M |
| 9/2016 | Inflazome | Series A | 17M |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 9/2020 | Syndesi Therapeutics | Series A | 7M |
| 2/2018 | Mainstay Medical | Post-IPO Equity | 37.5M |
| 9/2015 | Neuromod Devices | Series A | 7.7M |
| 10/2020 | Neuromod Devices | Series B | 12.4M |
| 10/2013 | Opsona | Series C | 0 |
| 4/2013 | Opsona | Series C | 0 |
| 4/2023 | Neuromod Devices | Series B | 0 |
| 5/2022 | Vivasure Medical | Series D | 0 |
| 3/2021 | XyloCor Therapeutics | Series A | 0 |
| 2/2021 | Mainstay Medical | Private Equity Round | 0 |
| 10/2010 | Cappella Medical Devices | Series D | 14.6M |
| 7/2009 | Cappella Medical Devices | Series C | 17.3M |
| 6/2022 | Ermium Therapeutics | Series A | 0 |
| 10/2020 | Priothera | Series A | 0 |
| 8/2018 | KaNDy Therapeutics | Series C | 32.6M |
| 8/2014 | Civitas Therapeutics | Series C | 0 |
| 1/2017 | NeRRe Therapeutics | Series B | 28.6M |
| 5/2023 | Dualyx | Series A | 0 |
| 2/2009 | Vivasure Medical | Series A | 11.6M |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 11/2009 | Genable Technologies Ltd. | Series B | 7.5M |
| 5/2023 | Dualyx | Series A | 0 |
| 4/2023 | Neuromod Devices | Series B | 0 |
| 7/2022 | MMI | Series B | 0 |
| 6/2022 | Ermium Therapeutics | Series A | 0 |
| 5/2022 | Vivasure Medical | Series D | 0 |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 7/2021 | NeRRe Therapeutics | Series B | 0 |
| 3/2021 | XyloCor Therapeutics | Series A | 0 |
| 2/2021 | Mainstay Medical | Private Equity Round | 0 |
| 1/2021 | Neurent Medical | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
